The invention provides a Chinese-Western compound pharmaceutical preparation for treating rheumatoid arthritis. The Chinese-Western compound pharmaceutical preparation comprises traditional Chinese medicine components and Western medicine components, wherein main materials of the traditional Chinese medicine components comprise beautiful sweetgum fruit, potentilla multifida, scorzonera divaricata, daphne kiusianavar. atrocaulis, brassica caulorapa Pasq., kohlrabi rhizoma curcumae, gentiana pubigera Marq., hypericum attenuatum, carpesium abrotanoides, dryopteris cycadina, glycine max (L.) Merr., cicada ecdysis, orchis, vaccinium laetum Diels, polytrchum commune, fissistigma oldhamii, loranthus parasiticus, garden balsam stem, rhynchelytrum repens, centipeda, thesium chinense Turcz., chinaroot greenbier rhizome, radix Et rhizoma nardostachyos, whorlleaf stonecrop herb, triblemma lanceum (Thunb.) Ching, vaccinium fragile Franch. var. mekongense (W. W. Sm.) Sleum., aralia undulata, boenninghausenia albiflora (Hook.) Meiss., and bottle gourd peel. The Western medicine components comprise prednisone acetate, chondroitin sulfate, acetaminophen, ribavirin, dextran, acetylsalicylic acid, docosahexenoic acid, casein phosphopeptides, evamisole hydrochloride and sorbitol. The pharmaceutical preparation is obvious in effect and low in cost.